ArticleInternational journal of dermatology2026

Minimal Disease Activity as A New Therapeutic Target in Atopic Dermatitis: A 5-Year Real-Life Experience With Dupilumab.

Francesco Leo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.